It is currently 20 Oct 2017, 07:54

### GMAT Club Daily Prep

#### Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

# Events & Promotions

###### Events & Promotions in June
Open Detailed Calendar

# Corporate Officer: Last year was an unusually poor one for

Author Message
VP
Joined: 26 Apr 2004
Posts: 1207

Kudos [?]: 821 [0], given: 0

Location: Taiwan
Corporate Officer: Last year was an unusually poor one for [#permalink]

### Show Tags

11 Dec 2004, 19:06
00:00

Difficulty:

(N/A)

Question Stats:

0% (00:00) correct 0% (00:00) wrong based on 1 sessions

### HideShow timer Statistics

Corporate Officer: Last year was an unusually poor one for our chemical division, which has traditionally contributed about 60 percent of the corporation's profits. It is therefore encouraging that there is the following evidence that the pharmaceutical division is growing stronger. It Contributed 45 percent of the corporation's profits, up from 20 percent the previous year.

On the basisc of the facts stated, which of the following is the best critique of the evidence presented above?

(A) The increase in the pharmaceutical division's contribution to corporation profits could have resulted largely from the introduction of a single, important new product.

(B)In multidivisional corporations that have pharmaceutical divisions, over half of the corporation's profits usually comes from pharmaceuticals

(C)The percentage of the corporation's profits attributable to the pharmaceutical division could have increased even if that division's performance had not improved.

(D) The information cited does not make it possible to determine whether the 20 percent share of profits cited was itself an improvement over the year before.

(E)The information cited does not make it possible to compare the performance of the chemical and pharmaceutical divisions in terms of the percent of total profits attributable to each

Kudos [?]: 821 [0], given: 0

Intern
Joined: 11 Dec 2004
Posts: 3

Kudos [?]: [0], given: 0

### Show Tags

11 Dec 2004, 21:12

Since contribution to profit by chemical division is down, that would increase the contribution to profit by other divisons.This can happen without even other divisions growing stronger.

Kudos [?]: [0], given: 0

11 Dec 2004, 21:12
Display posts from previous: Sort by